Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONE
826
DELISTED
CyrusOne Inc Common Stock
CONE
| $25.8M | 0.02% |
487,800
+44,211
| +10% | +$2.53M |
|
|
PRAH
827
DELISTED
PRA Health Sciences, Inc.
PRAH
| $25.7M | 0.02% |
279,161
-3,417
| -1% | -$346K |
|
828
Neurocrine Biosciences
NBIX
$16.8B
| $25.7M | 0.02% |
359,446
+14,216
| +4% | +$1.36M |
|
829
Wabtec
WAB
$49.1B
| $25.7M | 0.02% |
365,395
+9,502
| +3% | +$829K |
|
|
AAN.A
830
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $25.6M | 0.02% |
609,702
-5,299
| -0.9% | -$223K |
|
831
Old Republic International
ORI
$10.5B
| $25.6M | 0.02% |
1,245,849
+64,982
| +6% | +$1.39M |
|
832
Transocean
RIG
$5.89B
| $25.6M | 0.02% |
3,685,398
+464,134
| +14% | +$4.73M |
|
833
Brighthouse Financial
BHF
$3.56B
| $25.6M | 0.02% |
838,883
+1,212
| +0.1% | +$47.3K |
|
|
TWO
834
Two Harbors Investment
TWO
$1.27B
| $25.6M | 0.02% |
497,809
-9,500
| -2% | -$541K |
|
|
MIC
835
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $25.5M | 0.02% |
698,663
+26,346
| +4% | +$1.05M |
|
836
MKS Inc
MKSI
$20.1B
| $25.4M | 0.02% |
392,780
-1,711
| -0.4% | -$124K |
|
|
GRA
837
DELISTED
W.R. Grace & Co.
GRA
| $25.2M | 0.02% |
388,587
+9,889
| +3% | +$639K |
|
838
IPG Photonics
IPGP
$3.61B
| $25.2M | 0.02% |
222,561
+5,556
| +3% | +$739K |
|
839
Delek US
DK
$4.16B
| $25.2M | 0.02% |
775,541
-176,849
| -19% | -$6.69M |
|
|
GWR
840
DELISTED
Genesee & Wyoming Inc.
GWR
| $25.2M | 0.02% |
340,387
+1,701
| +0.5% | +$136K |
|
841
SITE Centers
SITC
$225M
| $25.2M | 0.02% |
2,916,805
-12,364
| -0.4% | -$116K |
|
842
Selective Insurance
SIGI
$5.65B
| $25.1M | 0.02% |
411,294
-463
| -0.1% | -$28.8K |
|
843
RenaissanceRe
RNR
$13.3B
| $24.9M | 0.02% |
186,247
+3,543
| +2% | +$463K |
|
|
ROIC
844
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $24.8M | 0.02% |
1,564,208
+72,132
| +5% | +$1.27M |
|
845
Ligand Pharmaceuticals
LGND
$5.76B
| $24.8M | 0.02% |
293,352
+16,318
| +6% | +$1.74M |
|
846
Wintrust Financial
WTFC
$10.8B
| $24.7M | 0.02% |
372,020
+1,988
| +0.5% | +$151K |
|
847
Avnet
AVT
$7.29B
| $24.7M | 0.02% |
684,684
-12,096
| -2% | -$494K |
|
848
Teladoc Health
TDOC
$1.22B
| $24.7M | 0.02% |
497,410
+4,927
| +1% | +$301K |
|
849
Brink's
BCO
$4.88B
| $24.7M | 0.02% |
381,316
-1,746
| -0.5% | -$115K |
|
850
Credit Acceptance
CACC
$5.95B
| $24.7M | 0.02% |
64,575
-727
| -1% | -$293K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.